arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ESTABLISHMENT LABS HOLDINGS INC.

ESTA
$77.28 ▼ -2.00 (-2.52%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
38 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

ESTABLISHMENT LABS HOLDINGS INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.3B
Dividend Yield
Revenue Growth 44.7%
Op. Margin -10.9%
ROIC -2.5%
FCF / Share $-0.21
Trailing P/E
Price / Book 153.6x
FCF Yield
Debt / Equity 16.82
info Valuation on last close. End-of-day price, Aug 7, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$59.88M
↑ +44.7%
Net Income Profit after all expenses
$-13.38M
↑ +35.4%
Operating Margin Operating profit as % of sales
-10.9%
↓ -78.8% 11th
FCF / Share Free cash flow per share
$-0.21
↑ +71.8%
Long-Term Debt Long-term obligations
$248.59M
— +0.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
9
Returns
1
Financial Health
22
Cash Quality
70

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 38 quarters